Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-001105

CHIEF EXECUTIVE OFFICER gave up 577 shares (to pay taxes)

  • CHIEF EXECUTIVE OFFICER acquired 1,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Williams Gregory C. · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-30 Exercise or conversion : show line 1 in the form +1,875 6,785 D
2020-04-30 Shares withheld for taxes : show line 2 in the form −577 $2.92 $1,685 6,208 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-04-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,875 20,625 D
Loading xslF345X03/form4-05012020_050506.xml…